Skip to main content
HCWB
NASDAQ Life Sciences

HCW Biologics Raises $4.0M in Deeply Discounted Private Placement Amidst Nasdaq Delisting Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.489
Mkt Cap
$17.374M
52W Low
$0.25
52W High
$9.2
52W Position info
896% above low
Off High info
73% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

HCWB has more than doubled off its 52-week low of $0.25.

Summary

HCW Biologics secured $4.0 million through a private placement of units, including common stock and warrants, priced at a significant discount to market, providing critical capital but at a high dilutive cost to existing shareholders.


Key Events · Financing and Capital Events · HCWB

  • Private Placement Priced at Deep Discount

    The company sold 2,846,975 units at a purchase price of $1.405 per unit, with the common stock component priced at $1.28 per share, significantly below the current market price of $2.4889.

  • Significant Capital Raise

    The offering generated approximately $4.0 million in gross proceeds, representing a substantial portion of the company's market capitalization, providing critical funding for operations.

  • High Dilution Potential

    The offering includes 427,046 shares, 2,419,929 pre-funded warrants, and 2,846,975 common warrants, leading to considerable potential dilution for existing shareholders.

  • Use of Proceeds

    Funds will support clinical trials for HCW9302, advance IND-enabling studies for HCW11-018b and HCW11-040, cover general corporate purposes, and pay off specific debts and settlements totaling $1.127 million.


Analysis · HCWB · Life Sciences

HCW Biologics has secured approximately $4.0 million in gross proceeds through a private placement of units, each consisting of common stock (or pre-funded warrants) and common warrants. The units were priced at $1.405, with the common stock component at $1.28, representing a significant discount to the current market price of $2.4889. This capital raise is critical for the company, which recently issued a going concern warning and received a Nasdaq delisting notice, and is seeking a reverse stock split. The proceeds will fund clinical trials, advance IND-enabling studies, cover general corporate purposes, and pay off specific debts totaling $1.127 million. While providing essential liquidity, the offering is highly dilutive, representing approximately 23% of the company's current market capitalization, with additional potential dilution from the warrants. This transaction follows a previously filed S-1 for a larger public offering, indicating the company's urgent need for capital under challenging terms.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCWB was trading at $2.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.4M. The 52-week trading range was $0.25 to $9.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCWB - Latest Insights

HCWB
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $0.8049 info
Change: -$0.2851 (-26%) info
Market Cap: $1.8M info
HCWB
Nov 05, 2026, 8:45 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $0.8049 info
Change: -$0.3551 (-31%) info
Market Cap: $1.8M info
HCWB
Oct 02, 2026, 4:30 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $1.68
Real-time Price: $0.8049 info
Change: -$0.8751 (-52%) info
Market Cap: $1.8M info
HCWB
Sep 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $0.8049 info
Change: -$0.8451 (-51%) info
Market Cap: $1.8M info
HCWB
Sep 24, 2026, 8:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $0.8049 info
Change: -$0.7951 (-50%) info
Market Cap: $1.8M info